Dr. Vinay Prasad, a controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency in May, has returned to his job weeks after resigning amid pressure from the White House and right-wing activist Laura Loomer.

Key Takeaways Vinay Prasad is returning as head of the FDA’s Center for Biologics Evaluation and ResearchHe was reportedly removed from his position July 29 after political criticism but is now returningThe White House decided the earlier criticisms were disingenuous MONDAY,

Vinay Prasad has returned to lead the US regulator’s Center for Biologics Evaluation and Research, resuming responsibility for oversight of vaccines, gene therapies and blood products. His reinstatement comes just over a week after stepping down from the role,